Accure Labs Private Limited — Oxaliplatin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Oxaliplatin · $2.6M export value · DGFT Verified
Accure Labs Private Limited is the #4 Indian exporter of Oxaliplatin with $2.6M in export value and 78 verified shipments. Accure Labs Private Limited holds a 5.5% market share in Oxaliplatin exports across 2 countries. The company exports 9 pharmaceutical products worth $11.1M across 2 therapeutic categories.
Accure Labs Private Limited — Oxaliplatin Export Profile: Buyers & Destinations
Where Does Accure Labs Private Limited Export Oxaliplatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| ALGERIA | $1.4M | 53 | 63.3% |
| MOROCCO | $730.4K | 25 | 33.7% |
| NEPAL | $39.9K | 11 | 1.8% |
| GAUTEMALA | $20.9K | 4 | 1.0% |
| GUYANA | $5.7K | 1 | 0.3% |
Accure Labs Private Limited exports Oxaliplatin to 5 countries. The largest destination is ALGERIA accounting for 63.3% of Accure Labs Private Limited's Oxaliplatin shipments, followed by MOROCCO (33.7%) and NEPAL (1.8%). These destinations reflect Accure Labs Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Oxaliplatin from Accure Labs Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PHARMACIE CENTRALE DES HOPITAUX | ALGERIA | $1.4M | 53 |
| TO THE ORDER | MOROCCO | $187.4K | 4 |
| BANQUE POPULAIRE BPCENTRE SUDCENTRE SUD SIEGE BP | MOROCCO | $132.4K | 5 |
| TO THE ORDER OF | MOROCCO | $108.1K | 3 |
| GETICS S A | GAUTEMALA | $15.6K | 1 |
| TAJ NEPAL PVT L T D | NEPAL | $12.9K | 3 |
| TAJ NEPAL PRIVATE LIMITED | NEPAL | $7.5K | 2 |
| TAJ ONCOTHERAPY PVT LTD | NEPAL | $6.5K | 2 |
| TAJ NEPAL PRIVATE L T D | NEPAL | $5.8K | 1 |
| NEW GPC INC | GUYANA | $5.7K | 1 |
Accure Labs Private Limited supplies Oxaliplatin to 14 buyers globally. The largest buyer is PHARMACIE CENTRALE DES HOPITAUX (ALGERIA), followed by TO THE ORDER (MOROCCO) and BANQUE POPULAIRE BPCENTRE SUDCENTRE SUD SIEGE BP (MOROCCO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Oxaliplatin Export Value and How Much Does Accure Labs Private Limited Contribute?
India exported $32.6M worth of Oxaliplatin through 3,081 shipments from 249 suppliers to 123 countries, serving 693 buyers globally. Accure Labs Private Limited contributes $2.6M to this total, accounting for 5.5% of India's Oxaliplatin exports. Accure Labs Private Limited ships Oxaliplatin to 5 countries through 14 buyers.
What Is the Average Shipment Value for Accure Labs Private Limited's Oxaliplatin Exports?
Accure Labs Private Limited's average Oxaliplatin shipment value is $33.1K per consignment, based on 78 shipments totaling $2.6M. The largest destination is ALGERIA (63.3% of Accure Labs Private Limited's Oxaliplatin exports).
How Does Accure Labs Private Limited Compare to Other Indian Oxaliplatin Exporters?
Accure Labs Private Limited ranks #4 among 249 Indian Oxaliplatin exporters with a 5.5% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($16.6M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($3.6M), ACCURE LABS PRIVATE LIMITED ($2.6M). Accure Labs Private Limited processed 78 shipments to 2 destination countries.
What Oxaliplatin Formulations Does Accure Labs Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| XYLATIN 100 (OXALIPLATIN INJECTION 100 M | $526.5K | 24 |
| XYLATIN 100(OXALIPLATIN INJECTION 100 MG)VLS | $376.1K | 9 |
| XYLATIN 50 (OXALIPLATIN INJECTION 50 MG) | $218.2K | 12 |
| XYLATIN 50(OXALIPLATIN INJECTION 50 MG)VLS | $119.2K | 5 |
| XYLATIN 100 PRIVATE OXALIPLATIN FOR INJECTION BATCH NO OX230301B MFG DT MAR 2023 EXP DT FEB 2025 | $100.0K | 2 |
| XYLATIN 100 MG PRIVATE OXALIPLATIN FORINJECTION 100 MG BATCH NO OX230302B MFG DT MAR 2023 EXP DT FEB 2025 | $87.4K | 2 |
| XYLATIN 100 (PRIVATE) (OXALIPLATIN FOR I | $86.9K | 2 |
| XYLATIN 100(OXALIPLATIN INJECTION 100 MG) | $82.8K | 2 |
| XYLATIN 100 (OXALIPLATIN FOR INJECTION 100MG) BCH NO-OX231201B MFG DT-DEC-2023 EXP DT-NOV-2025VLS | $62.5K | 2 |
| XYLATIN 50OXALIPLATIN INJECTION 50MGBATCH NO.OX230801AAS PER INV | $50.0K | 1 |
Accure Labs Private Limited exports 42 distinct Oxaliplatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is XYLATIN 100 (OXALIPLATIN INJECTION 100 M with 24 shipments worth $526.5K.
How Does Accure Labs Private Limited Compare to Nearest Oxaliplatin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | FRESENIUS KABI ONCOLOGY LIMITED | $16.6M | 602 | 24 | $27.6K |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $3.6M | 113 | 3 | $31.9K |
| 4 | ACCURE LABS PRIVATE LIMITED ★ | $2.6M | 78 | 2 | $33.1K |
| 2 | JODAS EXPOIM PRIVATE LIMITED | $1.6M | 32 | 1 | $50.0K |
| 7 | NAPROD LIFE SCIENCES PRIVATE LIMITED | $1.5M | 51 | 9 | $29.4K |
Accure Labs Private Limited ranks #4 among 249 Indian Oxaliplatin exporters. Average shipment value of $33.1K compared to the market average of $130.9K. The closest competitors by value are FRESENIUS KABI ONCOLOGY LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
Which Indian Ports Ship Oxaliplatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 535 | 17.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 453 | 14.7% |
| DELHI AIR | 436 | 14.2% |
| SAHAR AIR | 410 | 13.3% |
| CHAWAPAYAL ICD (INCPR6) | 110 | 3.6% |
| Bombay Air | 108 | 3.5% |
| NHAVA SHEVA SEA (INNSA1) | 97 | 3.1% |
| CHAWAPAYAL ICD | 95 | 3.1% |
What Other Advanced Oncology Products Does Accure Labs Private Limited Export?
Accure Labs Private Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Accure Labs Private Limited's Oxaliplatin Exports
Accure Labs' export operations are influenced by several geopolitical factors. The Israel-Iran conflict has heightened security risks in the Red Sea, leading major shipping lines to impose 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation increases shipping costs for Indian exporters, including Accure Labs, potentially affecting profit margins and delivery timelines. (sgeexport.com)
Conversely, the India-European Union Free Trade Agreement, signed in January 2026, eliminates tariffs on pharmaceuticals, enhancing Accure Labs' competitiveness in the European market. This agreement is expected to boost India's pharmaceutical exports by providing tariff-free access, thereby benefiting companies like Accure Labs. (en.wikipedia.org)
Additionally, the EU's Carbon Border Adjustment Mechanism (CBAM) introduces new compliance requirements for exporters. The Directorate General of Foreign Trade (DGFT) has established a 'CBAM Facilitation Cell' to assist exporters in meeting these standards. Accure Labs must adapt to these regulations to maintain its market position in Europe. (sgeexport.com)
Accure Labs Private Limited — Regulatory Compliance & Quality Standards
Accure Labs has proactively secured multiple international regulatory approvals, including European GMP accreditation in 2018 and Russian GMP certification in 2019. These certifications demonstrate the company's adherence to stringent quality standards, facilitating access to diverse global markets. (indiapharmaoutlook.com)
The evolving regulatory landscape, particularly the EU's CBAM, necessitates continuous compliance efforts. Accure Labs must ensure its manufacturing processes align with these environmental standards to sustain its export activities in the European Union. (sgeexport.com)
About Accure Labs Private Limited
Accure Labs Private Limited exports 9 products worth $11.1M. Beyond Oxaliplatin, top products include Gemcitabine, Paclitaxel, Irinotecan, Carboplatin, Temozolomide. View the complete Accure Labs Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Oxaliplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Oxaliplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Accure Labs Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 94 individual customs records matching Accure Labs Private Limited exporting Oxaliplatin, covering 42 formulations to 5 countries via 14 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 693+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Oxaliplatin Export Data from Accure Labs Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Accure Labs Private Limited's Oxaliplatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Accure Labs Private Limited
Full Company Profile →
9 products · $11.1M total trade · 2 categories
Oxaliplatin Stats
Company Overview
Top Products by Accure Labs Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Accure Labs Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Oxaliplatin. For current shipment-level data, contact TransData Nexus.